Latest Cannabis Market Shake-Ups: Record Revenue, Strategic Moves And Losses

The latest earnings reports and news from top cannabis companies reveal a mix of record growth, strategic shifts and financial moves. Aurora Cannabis hit new highs in medical revenue, while Ispire Technology trimmed lower-margin customers, causing a revenue drop. In the meantime, some big cannabis players made moves to strengthen balance sheets, expand operations and position for future growth.

Revenue Drops 51% As Company Shifts Strategy

Vape technology company Ispire Technology Inc. (NASDAQ: ISPR) reported a 51.4% decrease in revenue year-over-year to $20.3 million in the second quarter of fiscal 2026. That’s due to the strategic shift away from lower-quality cannabis customers, resulting in a decrease in overall product sales, the company said in a press release.

Gross profit followed a similar trend, dropping to $3.5 million in the same period compared to $7.7 million in the corresponding quarter of last year. Net loss improved over the same period to $6.6 million from $8 million in the second quarter of fiscal 2025.

Ascend Targets $120M Revenue With 25% EBITDA Margin In Q4

Multi-state, vertically integrated cannabis operator Ascend Wellness Holdings (CSE: AAWH-U) (OTCQX: AAWH) expects net revenue of roughly $120 million and adjusted EBITDA of approximately $30 million in the fourth quarter, representing an Adjusted EBITDA margin of 25%.

The company said recently it had cash and cash equivalents of roughly $86 million as of Dec. 31, 2025.

Canopy Growth Cuts Losses By Half, Eyes Global Expansion

Canadian cannabis giant Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) narrowed its third-quarter net loss by 49% year-over-year and adjusted EBITDA loss by 7% over the same period. The company reported on Friday consolidated net revenue of CA$75 million ($55.2 million) for the third quarter, flat compared to the three months ended Dec. 31.

The MTL Cannabis acquisition is on track to close this quarter, strengthening Canopy Growth’s global platform, while a January 2026 recapitalization improved the balance sheet and pushed all debt maturities to 2031, the company said last week.

Medical Cannabis Powers Aurora’s Growth

Another cannabis giant, Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) made headlines last week, reporting strong momentum in medical cannabis with record net revenue of $76.2 million achieved in the third quarter of fiscal 2026, up 12% year-over-year and representing 81% of total net revenue and 95% of adjusted gross profit.

Growth was driven mainly by Germany and Poland, with continued strength evidenced in Canada’s insurance-covered patient market, the company said in a press release. To support further growth, Aurora is launching four brand new websites to support key European markets. That said, Aurora’s central European platform will serve as a gateway to its dedicated regional websites in Germany, the UK, and Poland.

Aurora recently set up a new at-the-market equity offering program, allowing it to issue and sell up to $100 million of common shares, from time to time at Aurora’s discretion, at prevailing market prices. Aurora plans to use the proceeds for expanding cultivation capacity and potential merger and acquisition opportunities.

Debt Restructuring Puts Curaleaf In Growth Lane

Separately, Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF)announced on Monday a $500 million private placement of 11.5% senior secured notes due Feb. 1, 2029, with proceeds primarily earmarked to refinance its existing 2026 debt and support global growth initiatives, strengthening the company’s balance sheet and extending debt maturities to 2029.

Cannabist Sells Virginia Ops, Nets $130M for Debt Reduction

The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) wrapped up the sale of its Virginia cannabis operations last week to a Millstreet Credit Fund affiliate for $130 million.

The deal included dive operating dispensaries, one in development, and roughly 82,000 square feet of cultivation and production capacity. The company said it will use the proceeds to partially redeem senior secured notes due 2028, reducing debt and strengthening the balance sheet.